Heart Disease Trial, Recruiting NCT06900270 Sponsor: University of Sao Paulo General Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06900270
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have no history of heart disease, chest pain, heart attack, heart procedures, stroke, or circulation problems in the legs or other vessels (Group I)
  • People who have been found to have minor, non-blocking plaque or narrowing in the heart's arteries (less than 50% blockage), detected by a specialised heart scan or a procedure that looks inside the arteries (Group II)
  • People who have been found to have significant narrowing or blockage in the heart's arteries (50% or more blocked), detected by a specialised heart scan or a procedure that looks inside the arteries (Group III)

Who may not be able to join:

  • People who are not willing to sign the consent form to participate in the trial
  • People whose heart condition is not related to plaque build-up in the arteries, such as those with heart valve problems, heart muscle disease, or heart conditions present from birth
  • People with severely reduced kidney function (confirm with trial site for specific details)
  • People who have been diagnosed with cancer or another serious long-term illness with a poor outlook
  • People who have experienced an acute or sudden heart event (such as a heart attack or unstable chest pain) within the past 90 days
  • People who currently smoke

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Protasio da Luz PhD, Instituto do Coração InCor, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo

Phone: 55 11 2661-5795

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 July 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Identification of Differentially Expressed Proteins in Coronary Artery Disease Groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov